Haloperidol reduction can be assayed in human red blood cells
- 1 November 1989
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 67 (11) , 1468-1469
- https://doi.org/10.1139/y89-237
Abstract
One metabolite of haloperidol present in plasma is "reduced haloperidol." This study demonstrates that human red blood cells are capable of converting haloperidol to reduced haloperidol in vitro. The reductase involved requires NADPH, as does haloperidol (ketone) reductase in human liver cytosol.Key words: haloperidol reductase, human red blood cells, ketone reductase.This publication has 7 references indexed in Scilit:
- Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patientsBiological Psychiatry, 1989
- HALOPERIDOL REDUCTASE IN HUMAN AND GUINEA-PIG LIVERS1989
- Reduced Haloperidol/Haloperidol ratio and clinical outcome in schizophrenia: Preliminary evidencesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
- REVIEW OF HALOPERIDOL BLOOD LEVEL AND CLINICAL-RESPONSE - LOOKING THROUGH THE WINDOW1987
- Interconversions of haloperidol and reduced haloperidol in guinea pig and rat liver microsomesBiochemical Pharmacology, 1985
- Quantification of Reduced Haloperidol and Haloperidol by RadioimmunoassayJournal of Immunoassay, 1985
- Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection.Clinical Chemistry, 1983